CLINICAL-PHARMACOLOGY OF CALCIUM-ANTAGONISTS

被引：12

作者：

FOLLATH, F

TAESCHNER, W

机构：

来源：

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 1988年 / 12卷

关键词：

D O I：

10.1097/00005344-198812006-00024

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S98 / S100

页数：3

共 32 条

[21] NIFEDIPINE - RELATIONSHIP BETWEEN PHARMACOKINETICS AND PHARMACODYNAMICS [J].

KLEINBLOESEM, CH ;

VANBRUMMELEN, P ;

BREIMER, DD .

CLINICAL PHARMACOKINETICS, 1987, 12 (01) :12-29

[22]

KLEINBLOESEM CH, 1984, BR J CLIN PHARM, V19, P537

[23] EFFECTS OF NIFEDIPINE AND DILTIAZEM ON PLASMA-LEVELS AND RENAL EXCRETION OF BETA-ACETYLDIGOXIN [J].

KUHLMANN, J .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 37 (02) :150-156

[24] N-MONODESMETHYLDILTIAZEM IS THE PREDOMINANT METABOLITE OF DILTIAZEM IN THE PLASMA OF YOUNG AND ELDERLY HYPERTENSIVES [J].

MONTAMAT, SC ;

ABERNETHY, DR .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 24 (02) :185-189

[25] COMPARATIVE CARDIOVASCULAR ACTIONS OF VERAPAMIL AND ITS MAJOR METABOLITES IN ANESTHETIZED DOG [J].

NEUGEBAUER, G .

CARDIOVASCULAR RESEARCH, 1978, 12 (04) :247-254

[26]

SCHELLENS JHM, 1986, 3 WORLD C CLIN PHARM, P217

[27] REDUCED VERAPAMIL CLEARANCE DURING LONG-TERM ORAL-ADMINISTRATION [J].

SHAND, DG ;

HAMMILL, SC ;

AANONSEN, L ;

PRITCHETT, ELC .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (05) :701-703

[28] RANITIDINE AND CIMETIDINE - DRUG-INTERACTIONS WITH SINGLE DOSE AND STEADY-STATE NIFEDIPINE ADMINISTRATION [J].

SMITH, SR ;

KENDALL, MJ ;

LOBO, J ;

BEERAHEE, A ;

JACK, DB ;

WILKINS, MR .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 23 (03) :311-315

[29] PHARMACOKINETICS, BIOAVAILABILITY AND ECG RESPONSE OF VERAPAMIL IN PATIENTS WITH LIVER-CIRRHOSIS [J].

SOMOGYI, A ;

ALBRECHT, M ;

KLIEMS, G ;

SCHAFER, K ;

EICHELBAUM, M .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 12 (01) :51-60

[30]

TOWART R, 1982, ARZNEIMITTEL-FORSCH, V32-1, P338

← 1 2 3 4 →